You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
29 April 2026 - China-based biopharmaceutical company Shanghai Henlius Biotech Inc (HK:2696) and US healthcare company Organon (NYSE:OGN) announced on Wednesday that the European Commission has approved POHERDY (pertuzumab), the first biosimilar to P...
29 April 2026 - Clinical-stage pharmaceutical company Cirius Therapeutics Incannounced on Tuesday a planning grant from the Gates Foundation to advance the development of CIR-0602K as a potential postpartum therapeutic for women with a history of ges...
29 April 2026 - Insilico Medicine (HKEX:3696), a China-based, clinical-stage, generative AI-driven drug discovery company, announced on Tuesday that the inhalation solution of Rentosertib (ISM001-055), the company's first-in-class drug candidate...
29 April 2026 - Chinese biopharmaceutical company C-Ray Therapeutics (Chengdu) Co Ltd announced on Tuesday that its Type II Drug Master File (DMF) for COPPER [64Cu] CHLORIDE FOR RADIOLABELLING has been listed as active by the US Food and Drug Adminis...
28 April 2026 - Biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) announced on Tuesday that the US Food and Drug Administration (FDA) has accepted its New Drug Application for bepirovirsen for priority review in adults with chronic hepatitis B.T...
28 April 2026 - Danish biotechnology company Zealand Pharma A/S (CPH:ZEAL) reported on Tuesday that pharmaceutical company Boehringer Ingelheim has achieved positive Phase 3 results for survodutide, a glucagon/GLP-1 dual agonist, in the SYNCHRONIZE-1...
28 April 2026 - US healthcare company Johnson & Johnson (J&J) (NYSE:JNJ) announced on Monday that the US Food and Drug Administration (FDA) has granted Priority Review to the supplemental Biologics License Application (sBLA) for IMAAVY (nipoc...